Tci Wealth Advisors, Inc. Amneal Pharmaceuticals, Inc. Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$2.02 - $3.62 $5,413 - $9,701	2,680 New	2,680 $5,000
Q4 2021 Jan 24, 2022	SELL	$3.95 - $5.85 $2,445 - $3,621	-619 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$4.31 - $5.64 $2,667 - $3,491	619 New	619 $3,000
Q4 2018 Jan 17, 2019	SELL	$13.09 - $21.49 $772 - $1,267	-59 Closed	0 $0
Q2 2018 Jul 27, 2018	BUY	$13.95 - $20.2 $823 - $1,191	59 New	59 $1,000

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.27B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.